https://www.selleckchem.com/pr....oducts/epacadostat-i
ovel anti-asthmatic agent targeting the obese asthmatics. Since the introduction of stemless anatomic shoulder arthroplasty, few midterm functional and radiographic results have been published. This article presents results of the Arthrex Eclipse prosthesis with a mean follow-up of 70 months. We prospectively evaluated the outcome of 53 arthroplasties in 51 patients with a mean age of 65 years at the time of implantation with a minimum follow-up of 48 months. All patients were physically and radiologically examined, and t
Aimer
Commentaire
Partagez
